The QualityStocks Daily Thursday, August 12th, 2021

Today's Top 3 Investment Newsletters

QualityStocks(PBTS) $2.1000 +65.35%

MarketClub Analysis(XONE) $25.0800 +45.14%

Fierce Analyst(SPONF) $0.0315 +30.71%

The QualityStocks Daily Stock List

Avalon Holdings (AWX)

Wall Street Resources, StockMarketWatch, MarketClub Analysis, TradersPro, BUYINS.NET, Penny Pick Finders, MarketBeat, OTCtipReporter, PennyStockProphet, StreetInsider, Profitable Trader Authority, QualityStocks, StockOnion, Broad Street, TopPennyStockMovers, Buzz Stocks, CRWEFinance, CRWEPicks, CRWEWallStreet, DrStockPick, PennyOmega, Marketbeat.com, Planet Penny Stocks, OTCBB Journal, BestOtc, StockHotTips, PennyStockScholar, PennyToBuck and HotOTC reported earlier on Avalon Holdings (AWX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Avalon Holdings Corporation (NYSE American: AWX) is focused on the provision of waste management services to governmental, municipal, commercial and industrial customers.

The firm has its headquarters in Warren, Ohio and was incorporated in 1998, on April 30th. The firm serves consumers in the U.S.

The company operates through the Golf and related operations segment and the Waste management segment. The former segment manages and operates a travel agency, a hotel, four golf courses and associated clubhouses. On the other hand, the latter segment provides captive landfill management services, non-hazardous and hazardous waste disposal brokerage and management services and is also engaged in saltwater well operations. In addition to this, the segment is involved in the sale of construction mats and is also engaged in the provision of turnkey services which include management reporting, facilities management and daily operations.

The enterprise’s country club and golf facilities offer conference, banquet and dining facilities, tennis courts, fitness centers, spa services and swimming pools. It also operates and owns hotels under the Grand Resort brand, which offers many facilities including conference and banquet, salon and spa and cigar lounge facilities; bars, restaurants, fitness centers, bath, outdoor and indoor swimming pools and a tennis center. The enterprise’s subsidiary American Waste Management Services also helps customers to manage and dispose of waste at its disposal and treatment sites.

The firm recently released its financial results for 2021’s second quarter which show an increase in revenue and an increase in the basic net income per share, which not only benefits the firm’s shareholders but will also encourage more investments into the firm, which will be good for its growth.

Avalon Holdings (AWX), closed Thursday's trading session at $5.64, up 7.6336%, on 216,721 volume with 832 trades. The average volume for the last 3 months is 97,453 and the stock's 52-week low/high is $1.39999997/$6.07000017.

CBD Life Sciences, Inc. (CBDL)

QualityStocks, StockRockandRoll, PennyStockLocks and Penny Stock 101 reported earlier on CBD Life Sciences, Inc. (CBDL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

CBD Life Sciences, Inc.’s principal focus is to identify, evaluate and acquire undervalued opportunities with the aim of increasing shareholder value. The acquisition of LBC Bioscience, Inc. is the first in the CBD space. The Company is actively searching for additional opportunities within this developing sector. CBD Life Sciences lists on the OTC Markets. The Company is headquartered in Scottsdale, Arizona.

CBD Life Sciences announced this past March, that its wholly-owned subsidiary, LBC Bioscience, finalized the formulization for and is launching an organic - GMO free – CBD (cannabidiol) based anti-aging product line. The product line includes anti-aging day serum, CBD based eye gel, nourishing face serum with retinol, blemish balancing serum, CBD vitamin C face serum, and CBD based face cream. In addition, LBC Bioscience is working with Dr. Farhan Taghizadeh of Arizona Facial Plastics P.C. to develop a case study showing the effectiveness of the product line.

LBC Bioscience has also entered into negotiations to distribute its line of products in Japan. The initial order is $250,000. Ms. Lisa Nelson, President & Chief Executive Officer of CBD Life Sciences’ said this past April, “We are very excited about this opportunity to enter the Japanese market. The Japanese have embraced the benefits of CBD and we want to be on the forefront providing quality products to this aggressive expanding market.”

CBD Life Sciences previously announced that its LBC Bioscience completed the development of a disposable CBD vape-pen. This product is now undergoing final market testing. The anticipation is that it will be available for purchase within the next three to four weeks. LBC Bioscience is positioning itself to be a leader in the specialized CBD + e-cigarette vaping market.

Recently, CBD Life Sciences announced that LBC Bioscience is continuing to experience substantial revenue growth due to the expansion and market acceptance of its product lines. LBC is experiencing growth in retail sales. Moreover, it now being approached to provide ‘white label’ versions of its product lines. LBC Bioscience has developed and is retailing/wholesaling a complete line of cannabidiol based organic products. These include hemp drops, massage oils, pain relief creams, anxiety and sleep supplements, CDB edibles, anti-aging skin solutions and a full line of CBD infused supplements for pets.

CBD Life Sciences, Inc. (CBDL), closed Thursday's trading session at $0.0004, up 33.3333%, on 372,748,523 volume with 361 trades. The average volume for the last 3 months is 463.491M and the stock's 52-week low/high is $0.000199999/$0.019799999.

Cyber Security 1 AB (CYBNY)

QualityStocks and Stock Market Media Group reported earlier on Cyber Security 1 AB (CYBNY), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Cyber Security 1 AB is an international leader in Cyber Security. The Company provides cyber resilience solutions and conducts its operations through physical presences in Sweden, South Africa, the United Kingdom (UK), Kenya, Germany, Austria, Turkey, Greece, Italy, the Ukraine and the United Arab Emirates (UAE). The Company formerly went by the name Cognosec AB (publ). It changed its name to Cyber Security 1 AB in July of 2018. Cyber Security 1 AB is based in Stockholm, Sweden. The Company lists on the OTC Markets Group’s OTCQX.

Providing governance, risk, and compliance cybersecurity solutions, Cyber Security 1 provides solutions for client and information systems audit, penetration testing, application security assessment, and security monitoring. In addition, the Company provides solutions for urgent incident response and crisis management, data leakage and loss prevention, and network security and management.

Cyber Security 1 has a growing international footprint, an impressive client list, a flourishing mergers and acquisition (M&A) strategy and in 2019 a newly appointed Chief Executive Officer (CEO). Furthermore, Cyber Security 1 had revenues of 44.54m EUR in 2018 and employed 239 personnel at the end of Q4 2018.

Cyber Security 1 announced earlier this year an exclusive five-year partnership with Formula 1®, the world’s premier motorsport series. It will provide Formula 1® with an assortment of resilient solutions, designed to enhance and secure Formula 1’s infrastructure from potential cyber threats. Cyber Security 1 will work closely with the Information Technology (IT) department at Formula 1®, delivering a number of key projects. This includes consultancy, implementation, and advisory.

Cyber Security 1 recently announced the signing of exclusive Heads of Terms of Agreement pursuant to the acquisition of IntaForensics. Since IntaForensics’ formation in 2006, the business has grown worldwide to provide the widest variety of Digital Forensic and Cyber Security Services from its England headquarters.

IntaForensics is one of the fastest growing Digital Forensic Services providers globally. It is one of a few organizations that possesses the prestigious ISO/IEC 17025 Laboratory Standard. Additionally, it is accredited to ISO/IEC 27001 and ISO 9001. The business is accredited by the PCI Security Standards Council as a Qualified Security Assessor and a PCI Forensics Investigator (QSA, PFI).

Cyber Security 1 AB (CYBNY), closed Thursday's trading session at $0.54, up 40.6342%, on 12,379 volume with 11 trades. The average volume for the last 3 months is 1,392 and the stock's 52-week low/high is $0.159999996/$4.9499998.

DouYu International Holdings (DOYU)

MarketClub Analysis, Schaeffer's, Zacks, MarketBeat, InvestorPlace, TradersPro and StreetInsider reported earlier on DouYu International Holdings (DOYU), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

DouYu International Holdings Limited (NASDAQ: DOYU) (FRA: DY8A) is a holding firm that operates a platform on mobile applications and PC (personal computer) that offers entertainment live streaming services and interactive games.

The firm has its headquarters in Wuhan, the People’s Republic of China and was incorporated in 2014, on April 3rd by Wenming Zhang and Shaojie Chen. It serves consumers in China.

The company operates through the Livestreaming segment and the Advertisement and others segments. It generates most of its revenues through advertisement and live streaming and primarily operates its businesses in the domestic market. The company’s aim is to ensure a consistent supply of quality content by offering a sustainable streamer development system which is built on technology capabilities and infrastructure.

The enterprise’s platform helps connect publishers and game developers, eSports tournament viewers, advertisers and organizers and professional eSports players or teams. It also organizes eSports tournaments and sponsors eSports teams. This is in addition to streaming other content that includes a spectrum of live streaming entertainment options like travel, outdoor, music and talent shows. Furthermore, the enterprise allows streamers and viewers to edit and upload short videos of their content on their own as well as records and provides video clips that enable users to watch replays of selective live streaming content.

The firm is focused on increasing access to premium eSports content which helps to enhance user experience and attract even more viewers. This helps extend its consumer reach while encouraging more investments into the firm, which will in turn boost the company’s growth.

DouYu International Holdings (DOYU), closed Thursday's trading session at $3.44, off by 4.1783%, on 7,492,499 volume with 25,700 trades. The average volume for the last 3 months is 4.958M and the stock's 52-week low/high is $3.3900001/$20.5400009.

Houston American Energy (HUSA)

Wall Street Resources, UndiscoveredEquities, Jason Bond, StockMarketWatch, MarketBeat, The Street, StocksEarning, Stock Analyzer, TheStockfather, Dynamic Wealth Report, MonsterStocksPicks, BUYINS.NET, QualityStocks, Stock Stars, StreetInsider, The Online Investor, PowerRatings Stocks, PoliticsAndMyPortfolio, PennyPro, OTCPicks, TopPennyStockMovers, Mega Stock Picks, Mega Stock Pick, TradersPro, Trading Markets, Greenbackers, UltimatePennyStock and Promotion Stock Secrets reported earlier on Houston American Energy (HUSA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Houston American Energy Corp. (NYSE American: HUSA) is an independent energy firm focused on the acquisition, exploration, development and production of condensate, crude oil and natural gas properties.

The firm has its headquarters in Houston, Texas and was incorporated in 2001, on April 2nd. It serves consumers in South America and the United States Gulf Coast region.

The company’s gas and oil operations and assets are mainly found in the onshore Gulf Coast region, especially in Louisiana, Texas and Colombia. It manages its resources via divestitures and acquisitions. Its development and exploration projects are focused on future acquisition of more property interests in South America and in particular, Colombia, as well as the Texas Permian Basin, Louisiana and the onshore Texas Gulf Coast region. It is also focused on its existing property interests. The company also holds some acreage in Oklahoma.

The enterprise’s exploration and producing properties in Texas comprise of the Matagorda County while its properties in Louisiana include the Jefferson Davis Parish, the Assumption Parish, the Iberville Parish, the Vermilion Parish, the Plaquemines Parish and the East Baton Rouge Parish. As of December 2020, the enterprise owned interests in 4 gross wells, with reported proved reserves of over 115,000 barrels of oil equivalent.

As of November 2020, the firm had appointed a new CEO who brings with him years of industry experience and an understanding of the firm’s operations and assets, which will help bring in more opportunities to the company, which will be good for its growth.

Houston American Energy (HUSA), closed Thursday's trading session at $1.71, up 1.1834%, on 141,235 volume with 505 trades. The average volume for the last 3 months is 1.57M and the stock's 52-week low/high is $0.85799998/$6.36000013.

Lifeloc Technologies, Inc. (LCTC)

QualityStocks, TopPennyStockMovers, Stockgoodies, Outsider Club, Money Morning and Daily Trade Alert reported earlier on Lifeloc Technologies, Inc. (LCTC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Lifeloc Technologies, Inc. is a global leader in the development and manufacturing of breath alcohol and drug testing devices. The Company is a manufacturer of evidential breath alcohol testers and related training and supplies for Workplace, Law Enforcement, Corrections, and International customers. From its U.S. headquarters, Lifeloc designs, engineers, and manufactures precision, fuel cell based, breath alcohol testing equipment for professional and personal use. Lifeloc Technologies is headquartered in Wheat Ridge, Colorado.

The Company is a single source for alcohol testing equipment, drug screening supplies, and education. Lifeloc Technologies offers a complete line of Portable Breath Alcohol Testers (PBTs) and Evidential Breath Testers (EBTs). It provides a complete range of models incorporating its patented alcohol detection and sensing algorithms and using its platinum fuel cell technology. The Company’s professional units are tested and approved by the National Highway Traffic Safety Administration (NHTSA), a part of the U.S. Department of Transportation (DOT), and many State forensic and worldwide laboratories.

In the United States, Lifeloc Technologies supports its Workplace customers through a nationwide network of industry accredited and Lifeloc certified drug and alcohol training consultants. The Company assists organizations of all sizes in creating and managing their drug and alcohol testing programs.

The Company released its second generation, patent protected EasyCal® calibration station in 2019. This model is now capable of calibrating the entire line of Lifeloc professional breath alcohol testers. New features of the Company’s automated calibration station include RFID (radio frequency identification) registration of calibration gas standards. These features further automate the calibration process.

Lifeloc Technologies has its new platform of breath alcohol testers, the LX9 and LT7. The LX9 adds new modes of communication. Furthermore, the LX9 and LT7 have broad temperature use ranges. They are readily configurable for custom usages. The LX9 and LT7 models were added to the U.S. Department of Transportation’s conforming product list in November of 2019.

The Company’s marijuana breathalyzer remains an important target for product development. The ability of Lifeloc’s technology to detect delta-9-THC (Tetrahydrocannabinol) down to a concentration of 5 nanograms per milliliter and to collect a testable sample from a vapor stream has already been demonstrated in its laboratories.

Lifeloc Technologies, Inc. (LCTC), closed Thursday's trading session at $6.15, up 49.635%, on 23,155 volume with 158 trades. The average volume for the last 3 months is 1,253 and the stock's 52-week low/high is $1.50/$6.9499998.

Powerbridge Technologies Co. (PBTS)

QualityStocks, StockMarketWatch, MarketBeat, StreetInsider and BUYINS.NET reported earlier on Powerbridge Technologies Co. (PBTS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Powerbridge Technologies Co. Ltd. (NASDAQ: PBTS) is focused on the provision of software application and technology services and solutions, mainly in China.

The firm has its headquarters in Zhuhai, the People’s Republic of China and was incorporated in 1997 by Shiang Stewart Lor and Ben B. Lor. It operates in the technology sector, under the software and tech services industry in the software sub-industry and serves government and corporate customers across the globe.

The company sells its services and solutions via strategic government partners, indirect channel partners and direct sales organization and serves logistics service providers, government authorities and agencies and international trade manufacturers and businesses. The company generates its revenue in the form of subscription services, technical support and consulting services and application development services. All the company’s revenue is generated from China.

The enterprise provides insurance and export & import loan processing for consumers to streamline their regulatory compliance, trade logistics and trade operations as well as system solutions, including trade compliance and trade enterprise. It also offers Powerbridge Blockchain-as-a-service, which is made up of supply chain blockchain services and compliance blockchain services; and Powerbridge Software-as-a-service solutions, which comprises of Insurance and export & import loan processing service cloud, cross-border ecommerce cloud, inward processed manufacturing cloud, trade one operations cloud and logistics service cloud.

The company recently initiated its Smart City Operation Platform which the firm believes will play a key role in the digitalization of cities in China. The move helps to extend the company’s reach, which will in turn, boost its growth.

Powerbridge Technologies Co. (PBTS), closed Thursday's trading session at $2.1, up 65.3543%, on 259,764,462 volume with 475,450 trades. The average volume for the last 3 months is 6.786M and the stock's 52-week low/high is $1.07000005/$9.64999961.

Sunshine Biopharma (SBFM)

QualityStocks, Investor Ideas, PennyStocks24, Ceocast News, Stock Twiter, OTCPicks, Gorilla Stock Trades, Pennybuster, Jet-Life Penny Stocks, AllPennyStocks, Fast Money Alerts, FeedBlitz, Greenbackers, Investor Stock Alerts, Ironman Stock, MassiveStockProfits, 007 Stock Chat, Otcstockexchange, Winston Small Cap, Penny Stock General, PennyStockSpy, Shiznit Stocks, Stock Roach, Stock Shock and Awe, StockHideout, Whisper from Wall Street and Mina Mar Marketing Group reported earlier on Sunshine Biopharma (SBFM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Sunshine Biopharma Inc. (OTC: SBFM) is a pharmaceutical firm that is engaged in researching, developing and commercializing therapies for different forms of cancer.

The firm has its headquarters in Pointe-Claire, Canada and was incorporated in 2006, on August 31st. It is part of the drug wholesaler’s industry and operates in the healthcare sector under the biotech and pharma sub-industry.

The company is party to a license agreement with the University of Georgia to further advance developing a pair of anti-Covid-19 compounds in parallel with SBFM-PL4, its anti-Covid-19 lead compound. Its goal is to become a fully integrated pharmaceutical firm that offers proprietary and generic drugs for treating cancer and other chronic and acute indications. Its products include Essential 9, SBI-Finasteride, SBI-Bicalutamide, SBI-Letrozole, SBI-Anastrozol and Adva-27a.

Its product pipeline includes an anti-coronavirus treatment compound dubbed SBFM-PL4; a dietary supplement tablet named Essential 9 and a GEM-difluorinated C-glycoside derivative of podophyllotixin dubbed Adva-27a which is indicated for the treatment of liver, ovarian, colon, bladder, prostate, brain, lung, testicular, lymphoma, leukemia and other cancer types, as well as eliminating multidrug resistant cancer cells, including uterine sarcoma cells, small-cell lung cancer, breast cancer and pancreatic cancer. In addition to this, it also offers generic prescription drugs for treating benign prostatic hyperplasia, prostate cancer and breast cancer.

The American Cancer Society approximates that over a million individuals are diagnosed each year with cancer in the U.S., noting that more than 11 million Americans are currently living with cancer. The company may soon introduce a new cancer treatment into the market, which will be beneficial to patients suffering from these ailments as well as company stakeholders.

Sunshine Biopharma (SBFM), closed Thursday's trading session at $0.13475, up 32.7586%, on 7,435,170 volume with 782 trades. The average volume for the last 3 months is 7.045M and the stock's 52-week low/high is $0.009999999/$0.31400001.

Two Hands Corporation (TWOH)

Penny Stock General, Shiznit Stocks, StockRockandRoll, Penny Stock 101, PennyStockLocks, Penny Stock Titans, QualityStocks, Penny Picks, Damn Good Penny Picks, Profitable Trader Authority, OTCtipReporter, PennyStockScholar, Stock Commander, Small Cap Firm, GrowthPennyStocks, Fierce Analyst, BeatPennyStocks, PennyStockProphet, StockWireNews, Penny Pick Finders, StockOnion, Monster Alerts, Buzz Stocks, Insider Financial, MicroCapDaily, MassiveStockProfits, InvestorSoup, Epic Stock Picks, HotOTC, Make Penny Stocks Great Again, Beacon Equity Research, Penny Stock Finder, Wolf of Penny Stocks, ProTrader, Stock Preacher, StockHideout, Penny Stock Craze, OTCMagic, Penny Stock 106, Penny Stock Prodigy, PennyStockLocks.com, Explicit Penny Picks, StockStreetWire, Wealth Insider Alert and Winston Small Cap reported earlier on Two Hands Corporation (TWOH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Two Hands Corporation is a top custom application development company. Its focus is on creating a complete co-parenting solution, delivering tools that enable co-parents to better collaborate about parental responsibilities, in a clear and positive way. The Company formerly went by the name Innovative Product Opportunities, Inc. It changed its name to Two Hands Corporation in September of 2016. Founded in 2009, Two Hands Corporation has its head office in Toronto, Ontario.

The Company’s "Two Hands" web application launched in July of 2018. Two Hands’ ultimate aim is to improve the lives of families affected by divorce. Two Hands states that "Two Hands" is an ideal solution that will reduce the stress and worries of co-parenting.

Concerning its other offerings, Two Hands’ Gone App enables one to send encrypted text messages right from their phone, combining military-grade security, confidentiality, and privacy – with first-rate convenience, right at their fingertips. All text messages are asymmetrically encrypted. It is safe, with keys that only the rightful user owns. Gone App features Message Auto-Deletion after being read; no preview, one must click to view the message; and Screen Capture is disabled.

Moreover, Two Hands Corp Lab is an organic hemp based CBD (cannabidiol) cultivator located in Colombia. Two Hands Corp Lab is vertically integrated, producing from seed to wholesaler. It will distribute its high grade hemp based oil primarily through Latin America and Australia. In addition, it will expand its reach once countries allow for importation.

Two Hands Corporation has diversified. This is to meet new demand for online delivery due to the current Covid-19 Pandemic. In May of this year, the Company announced it was ready to launch the GoCart brand of grocery delivery applications in early June. Its GoCart Online Grocery Delivery set of applications will be rolled out in stages to meet the growing demand for online grocery delivery.

GOCART.CITY offers farm fresh, artisanal, and specialty grocery selections, delivered right to one’s doors. Customers can easily choose their choice of fresh produce, quality cut fruits and vegetables, and a wide variety of day-to-day grocery items. According to a February 2020 report by CBC, the expectation is that online grocery delivery will grow anywhere between 5-7 percent over the next decade. That equates to almost $15 billion worth of business. GOCART.CITY services the Greater Toronto Area.

Two Hands Corporation (TWOH), closed Thursday's trading session at $0.0049, up 32.4324%, on 642,658,522 volume with 2,625 trades. The average volume for the last 3 months is 80.607M and the stock's 52-week low/high is $0.001599999/$0.013.

Western Copper and Gold (WRN)

Vantage Wire, MarketBeat, TradersPro, Streetwise Reports, Wealth Insider Alert, Wall Street Resources, Top Pros' Top Picks, The Street, Super Stock Picker, StockOodles, Stockhouse, SmallCapVoice, QualityStocks, Investopedia and FeedBlitz reported earlier on Western Copper and Gold (WRN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Western Copper and Gold Corporation (NYSE American: WRN) (TSE: WRN) (FRA: 31WN) is an exploration stage firm that is focused on the exploration and development of the Casino mineral property.

The firm has its headquarters in Vancouver, Canada and was incorporated in 2006, on March 17th. Prior to its name change in October 2011, the firm was known as Western Copper Corporation. The firm serves consumers in Canada.

The company explores for molybdenum, copper and gold deposits. Its operations are mainly directed toward the acquisition, exploration and future development of resource properties in Canada. Its subsidiaries include Minera Costa de Plata S.A. de CV, Ravenwolf Resource Group Limited and Casino Mining Corp. It is yet to generate any revenue from its mining operations.

The enterprise’s precious metal properties include the Bonanza, Nolan, Betty and White Gold properties. It is primarily engaged in the development of the Casino project into Canada’s premier copper-gold mine. The Casino copper-gold-molybdenum-silver project is found in the Yukon, in Canada. This flagship property, which is a copper-gold-molybdenum porphyry deposit, comprises of 55 placer claims and 1135 partial and full quartz claims. The Casino project is made up of proven and probable reserves of more than 160 million tons of heap leach and roughly 960 million tons mill ore.

The firm has drilling programs for diamonds planned for some of its properties, including the Nolan and Betty properties. Success in these programs will help generate revenue for the firm as well as encourage more investments into the firm, which will have a positive effect on the company’s growth.

Western Copper and Gold (WRN), closed Thursday's trading session at $1.7, off by 3.9548%, on 220,949 volume with 773 trades. The average volume for the last 3 months is 794,278 and the stock's 52-week low/high is $0.949999988/$2.82999992.

Westport Fuel Systems (WPRT)

StreetInsider, The Street, StreetAuthority Daily, TopStockAnalysts, InvestorPlace, Wealth Daily, TraderPower, Daily Wealth, The Motley Fool, TheStockAdvisor, MarketClub Analysis, Energy and Capital, BUYINS.NET, MarketBeat, Investor Ideas, StockMarketWatch, Profit Confidential, Street Insider, Investor Guide, InvestorGuide, Hit and Run Candle Sticks, Alternative Energy, The Growth Stock Wire, Weekly Wizards, Wealthpire Inc., Investor Update, VectorVest, AllPennyStocks, ProfitableTrading, Cabot Wealth, CNBC Breaking News, Daily Trade Alert, BullRally, Greenbackers, FNNO Newsletters, Dynamic Wealth Report, HotOTC, PennyStockVille, CoolPennyStocks, FreeRealTime, SmarTrend Newsletters, TradingMarkets, Trades Of The Day, TradersPro, StreetAuthority Financial, StockTwits, StockRich, Money Morning, Stock Gumshoe, Inside Investing Daily, Schaeffer's, QualityStocks, PennyInvest, MadPennyStocks, Louis Navellier, Investing Futures and StockEgg reported earlier on Westport Fuel Systems (WPRT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Westport Fuel Systems Inc. (NASDAQ: WPRT) (TSE: WPRT) (FRA: WP1A) is focused on the manufacture and supply of alternative fuel components and systems which are used in transportation applications globally.

The firm has its headquarters in Vancouver, Canada and was incorporated in 1995, on March 20th. Prior to its name change in June 2016, the firm was known as Westport Innovations Inc. It operates as part of the oil and gas extraction industry and has twenty companies in its corporate family. The firm serves consumers across the globe.

The company operates through the Corporate segment, the Joint venture and Cummins Westport Inc. segment and the Transportation segment. The corporate segment is involved in general administrative duties, corporate oversight and public company activities while the joint venture segment serves the heavy-duty and medium duty highway engine markets. On the other hand, the transportation segment is engaged in the design, manufacture and sale of components for transportation applications and alternative fuel systems. The company markets its products mainly under the AFS, Valtek, TA Gas Technology, Zavoli, Emer, GFi Control systems, OMVL, Westport, BRC Gas Equipment and Cummins Westport brands.

The enterprise provides alternative fuel components and systems, which include alternative fuels like hydrogen, liquefied natural gas and compressed natural gas. It also offers a fully integrated system known as the Westport High Pressure Direct Injection 2.0 which decreases greenhouse gas emissions by powering compression ignition engines using natural gas. In addition to this, the enterprise is involved in the development, sale and marketing of propane and park-ignited natural gas engines. Its services and products are used for passenger vehicles, heavy-, medium- and light-duty trucks and cryogenics.

The firm recently released its financial results for 2021’s second quarter, with its CEO noting that the firm’s business outlook was strong. With the need for cleaner transportation solutions growing, the firm is set to make big bucks in the near future while expanding into new territories, which will be good for the company’s growth.

Westport Fuel Systems (WPRT), closed Thursday's trading session at $4.72, off by 4.6465%, on 1,672,332 volume with 10,520 trades. The average volume for the last 3 months is 2.436M and the stock's 52-week low/high is $1.54999995/$12.9499998.

Myomo, Inc. (MYO)

TraderPower, StockMarketWatch, MarketClub Analysis, BUYINS.NET, MarketBeat, QualityStocks, Buzz Stocks, HotOTC, OTCtipReporter, Penny Pick Finders, PennyStockProphet, Profitable Trader Authority, Zacks, SeeThruEquity Research, StockOnion, StreetInsider, TopPennyStockMovers, TradersPro and PennyStockScholar reported earlier on Myomo, Inc. (MYO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

2Q:22 Results Exceed Our Estimates As Revenue Triples

Myomo (NYSE American: MYO) was featured in a company-sponsored research earnings release note published by Sidoti & Company, LLC. The report reads, “There are now more 898 units waiting for reimbursement approval, compared to 768 units at the end of 2020… We expect order rates in the United States to accelerate as reimbursement improves.”

To access the full report, visit https://ibn.fm/NqnKh

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. It is currently the only marketed device that, sensing a patient’s own EMG signals through non-invasive sensors on the arm, can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. Please visit www.myomo.com.

Myomo, Inc. (MYO), closed Thursday's trading session at $10.07, up 5.2247%, on 86,520 volume with 967 trades. The average volume for the last 3 months is 75,940 and the stock's 52-week low/high is $3.46000003/$18.8799991.

The QualityStocks Company Corner

Streamlytics

The QualityStocks Daily Newsletter would like to spotlight Streamlytics

Streamlytics Is ‘One to Watch’

  • Streamlytics helps consumers get paid for their data through its proprietary Data Valuation algorithm
  • The company is the largest first-party provider of African American data
  • Streamlytics has a patent-pending new data standard, the Universal Data Interchange Format, that powers the company’s data unification
  • The global alternative data market was valued at $1.06 billion in 2019 and is expected to grow at a CAGR of 40.1% to reach more than $8 billion by 2027
  • The global artificial intelligence market was valued at $62.35 billion in 2020 and is expected to achieve a CAGR of 40.2% from 2021 to 2028
  • Streamlytics is a minority-owned, women-led company
  • The company’s founder is one of Fast Company’s 100 Most Creative, Inc. Magazine’s Female Founders 100, ADWEEK’s Women Trailblazers, Goldman Sachs 100 Most Intriguing Entrepreneurs, and Business Insiders’ 25 Most Influential African Americans in Technology

Streamlytics provides ethical, people-powered data, spanning millions of data points from today’s fastest growing communities across the United States. The company unlocks the power of actual data usage, reflective of how people create data today – simultaneously across all types of platforms, not by rigid panels or unethical tracking. By partnering with consumers across the nation, the company has gained unparalleled access to audiences’ and shoppers’ content consumption and purchasing patterns across Netflix, Google, Amazon and more.

Streamlytics’ first consumer facing data acquisition app allows African American consumers to own their data through a data license, value their data with its proprietary data valuation algorithm, and get fairly paid for their data. The result is ethical data transactions and unmatched insight into the decisions that consumers are making across platforms. The company’s data signals are not limited to purchase and content consumption. The breadth of activity spans fitness, health and universal mobility. The current archaic model of consumer data collection across many industries is to use second- or third-party assumptive data based on cookies or affinities, which has a high margin of error causing an enormous amount of waste in financial resources for client organizations. Streamlytics provides clear, accurate, full-spectrum data, delivering the true picture of a coveted consumer group’s activity across their digital footprint.

Since its founding, the company’s mission has been to disrupt the deceptive online data collection processes that have become commonplace. Streamlytics’ drive to prioritize consumer data collection transparency and ethics has led to tremendous growth. The company recently announced it had reached a milestone of more than a quarter-billion data points. Streamlytics’ impressive growth over the past year is largely due to expansion, adding platforms like Apple, Uber, Uber Eats, Postmates and others. The company’s patent-pending data standard, Universal Data Interchange Format (UDIF), powers the unification of cross-platform data sources and formats into a single unified data format. Streamlytics leads the industry in consumer data unification, which is increasingly valuable as companies look to navigate away from third-party data solutions and integrate ethical first-party data across corporate strategy, product innovation, artificial intelligence, marketing and more.

How it Works

Streamlytics unifies consumer data from today’s fastest growing communities across popular platforms spanning over 400 million data points. We ethically unlock the power of actual usage data (directly from the source) and help companies grow by enhancing their 1st-party data strategy across sales, marketing, product, and artificial intelligence.

Streamlytics data enhances existing measurement tools by focusing on density. The company’s approach provides a number of benefits over traditional data sourcing platforms, including:

  • Multidimensional data that offers visibility into consumption behaviors that define decision drivers for consumers
  • An integrated approach that connects a variety of data sources and types to paint the clearest picture of consumer behavior
  • A clear understanding of the consumer, allowing for greater targeting precision that directly impacts the effectiveness of campaigns
  • Ethical sourcing, with consumers directly compensated for their data
  • Protection of all personal identifying information (PII) to ensure privacy and security

The company sells data that has been ethically sourced through a Standard Datastream (a streamlined feed consisting of roughly 22.5 million data points) and a Custom Datastream (a full spectrum feed spanning over 150 million data points). Client organizations subscribe to either datastream, based on the specific audiences they want to reach. Organizations most often use Streamlytics data to enhance their first party data strategies in an effort to increase revenue and sales, refine corporate strategy and enhance machine learning training data to reduce algorithmic bias.

Market Outlook

The global alternative data market was valued at $1.06 billion in 2019 and is expected to grow at a CAGR of 40.1% to reach more than $8 billion by 2027. The global artificial intelligence market was valued at $62.35 billion in 2020 and is expected to achieve a CAGR of 40.2% from 2021 to 2028, according to data from Grand View Research.

Streamlytics believes a new market space is emerging at the intersection of these two thriving industries called ‘Community Driven Data’, which will comprise consumers who have opted in to share their data, and companies that decide using ethically sourced data is better than fines and negative media coverage they could get from continuing to do it the old way.

Streamlytics has positioned itself as the leader of this emerging new market space as consumers increasingly opt out of sharing their data under the current model, and as new laws – like Prop 24, the California Consumer Personal Information initiative passed overwhelmingly by voters in 2020 – mandate greater privacy protections for, and limits on corporate use of, consumer data.

Management Team

Angela Benton is founder and CEO of Streamlytics. She is a pioneer of diversity in the technology industry and of raising awareness around the inequalities that exist in the industry. In 2011, she founded NewME, the first entrepreneurial accelerator globally for minorities. Through her leadership, NewME has accelerated hundreds of entrepreneurs, helping the nascent companies to raise more than $47 million in venture capital funding. That company was acquired in 2018.

Arisha Smith is the Chief Revenue Officer of Streamlytics. An innovator in advertising technology, she has designed growth strategies for businesses leveraging digital, social and mobile platforms for over 20 years. She has held marketing positions at Accenture and Microsoft, as well as at Vibe Media. She earned an MBA from Florida A&M University.


Recent News

chart

Asia Broadband Inc. (OTC: AABB)

The QualityStocks Daily Newsletter would like to spotlight Asia Broadband Inc. (AABB).

Silver has had many applications in the past, its use in jewelry for millenniums to its use in powering the current new tech innovations and the green energy transition. The metal, which has the greatest electrical conductivity in comparison to all other metals, is also used in 5G devices, circuit boards, electric vehicles, electrical contacts and solar panels, among other devices. For all its uses and applications, the full process of extracting the mineral isn’t well known. We discuss this extraction and refining process of this metal, which is growing in demand, below. From the above, one can see that silver’s production involves a lot of processes and with its demand set to see a more than 10% year-over-year increase, more sustainable and highly efficient ways to extract the metal from the ground will be needed. That challenge is already being addressed by forward-looking precious and base metals firms, including Asia Broadband Inc. (OTC: AABB), whose hallmark of continuous improvement touches every aspect of their operations.

Asia Broadband Inc. (OTC: AABB) is a resource company focused on the production, supply and sale of precious and base metals, primarily to Asian markets.

The company utilizes its specific geographic expertise, experience and extensive industry contacts to facilitate its innovative distribution process from the production and supply of precious and base metals in Mexico to client sales networks in Asia. This vertically integrated approach to sales transactions differentiates Asia Broadband from its competitors in the mining space.

Development Program in Colima, Mexico

In October 2020, Asia Broadband announced its acquisition of a high potential mineral property in the state of Colima, Mexico. Per the press release, previous geophysics and groundwork have revealed strong indications of significant mineralization in multiple sectors of the property.

The company recently began the construction of exploration and development facilities and infrastructure roads on its Colima property, and plans are underway to extend previous geophysics and groundwork on the property. In January 2021, Asia Broadband announced its allocation of $10 million for the initial development program, with the aim of accelerating operations at the Colima site toward production.

Positioned in a major gold-iron-copper production area, the company’s Colima property is situated approximately 25 kilometers east of the Pena Colorada mine in Minatitlan, Mexico. It is advantageously located, with direct access to main Highway #3, and the property also has an essential natural water supply.

AABB Gold Token

In December 2020, Asia Broadband announced its entry into a definitive development agreement with Core State Holdings Corp., a digital assets and crypto wallet creator, to produce a white label gold-backed cryptocurrency coin. The AABB Gold token is an ERC-20 token being developed on the Ethereum blockchain.

In a February 2021 news release, the company provided a development update on the cryptocurrency token, noting that Core State Holdings Corp. “is continuing to modify the set-up and move through the final stages of testing of the iOS and Android AABB Wallet applications, including the implementation of an application interface to allow users to see the real-time exchange rate of gold that backs the price of the AABB Gold token set at one-tenth of a gram or approximately $5.80 USD.”

Core State Holdings Corp. has also continued to enhance www.AABBGoldToken.com, which the company notes will be the go-to knowledge base for all information concerning the soon-to-be launched AABB Wallet and AABB Gold token.

AABB’s primary goal for the token is to become a worldwide standard of exchange – secured and trusted with gold backing – by expanding circulation and targeting large population and high growth markets globally, including China and East Asia.

Asia Broadband Inc. (AABB), closed Thursday's trading session at $0.12025, off by 5.315%, on 15,893,678 volume with 1,198 trades. The average volume for the last 3 months is 20.183M and the stock's 52-week low/high is $0.0026/$0.658999979.

Recent News

Sugarmade, Inc. (OTC: SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (OTC: SGMD).

Sugarmade (OTC: SGMD), an emerging leader in the vertically integrated cannabis marketplace based in California, today provided current and prospective shareholders with an update on its recent acquisition, Lemon Glow Company Inc. The acquisition included all of Lemon Glow’s assets, interests, property, and rights, including 640 acres of real estate (the “property”) located in Lake County, California, outside of the Commercial Cannabis Cultivation Exclusion Zones. “We are pleased to report that we have been able to successfully comply with the requirements attached to this acquisition process,” said Sugarmade CEO Jimmy Chan. “Lemon Glow is a pivotal asset in our verticalization process because it represents a large-scale outdoor cannabis cultivation opportunity. The annual potential cultivation yield at the property has been approximated at 4,000 pounds of dry trimmed cannabis flower per acre, per year, which represents approximately 128,000 pounds, or 64 tons, of dry trimmed cannabis flower per year in total. We also stand to benefit from this acquisition because we gain very valuable personnel, including Lemon Glow’s executive team, who will stay on and become core management in our cannabis cultivation, which positions Sugarmade’s grow segment with a top management team with over 30 years of cannabis cultivation experience.” To view the full press release, visit https://ibn.fm/VqBiQ

Sugarmade, Inc. (OTC: SGMD) is a product and brand marketing company investing in operations and technologies with disruptive potential. The company is focused on collaborating with real people in real-time to identify the emerging desires and behaviors poised to unlock new opportunities and pathways for growth. Sugarmade seeks to redefine the marketplace by nurturing an innovative and compelling relationship between brand, botany and business – resulting in both undeniable consumer value and an intriguing cross-pollination of revenue sources.

The company’s core strategic plan is centered on expanding its end-market access as a central player in the growing California cannabis delivery marketplace while developing its in-house cannabis production capacity to verticalize operations in the space. Through a combination of organic growth and strategic acquisitions, Sugarmade intends to develop a full farm-to-door vertically integrated cannabis business.

Brand Portfolio

Sugarmade has investments in a number of subsidiaries with active operations in the California cannabis sector. These include:

  • NUG Avenue – Sugarmade owns a 70% stake in NUG Avenue, a cannabis delivery service based in Southern California providing hand-selected top-shelf products from Stiiizy, Kanha, PlugPlay and more.
  • BudCars – Sugarmade is an investor in cannabis delivery service of BudCars’ first operating location in Sacramento, California. BudCars is an online-shopping experience designed to provide new customers with an easy way to discover and order cannabis products within minutes.

Acquisition of Lemon Glow Company

On May 17, 2021, Sugarmade took a major step toward closing the loop on what its management team believes to be one of the most promising vertically integrated cannabis models in the thriving California market when it announced the signing of a definitive agreement for its acquisition of Lemon Glow Company Inc.

The Lemon Glow acquisition includes 640 acres of property, 32 of which have already been designated for outdoor cannabis cultivation. Per the company’s news release, the annual potential cultivation yield at the property is estimated to be approximately 4,000 pounds of dry trimmed cannabis flower per acre per year, which represents approximately 128,000 pounds, or 64 tons, of dry trimmed cannabis flower per year in total.

Notably, Sugarmade also benefits from the acquisition in terms of team capital, as Lemon Glow executive team members will stay on and become the core management team at the cannabis cultivation site, granting the operation over 30 years of cannabis cultivation experience.

“The Lemon Glow team are tremendous additions to the Sugarmade team,” Jimmy Chan, CEO of Sugarmade, commented in announcing the definitive agreement. “They have vast experience and established skills, as well as intricate knowledge of the property and its local grow context. That’s an enormous added value proposition in this deal. We look forward to bringing them on board, ramping up operations at the property, and taking key steps toward delivering on the promise of Sugarmade’s farm-to-door vision.”

Market Opportunity

The California cannabis industry has continued to record tremendous growth since voters approved a measure to legalize recreational use of the plant in 2016. According to data from MJBizDaily, California’s legal market hit $4.4 billion in sales in 2020, up from $2.8 billion in 2019 and $1.4 billion in 2018.

Those figures highlight California’s status as the largest legal cannabis market in the world. With roughly 28 million residents over the age of 21, California is more than twice the combined size of the four states (Arizona, New Jersey, Montana and North Dakota) that legalized cannabis in 2020.

The COVID-19 pandemic was a key driver in the growth of cannabis delivery services throughout the state in 2020. One California cannabis delivery firm reported a 60% increase in new delivery customer sign-ups in the 30 days following the March 13, 2020, declaration of a national emergency. As a result of this boom, tech companies in cannabis ecommerce were able to dramatically increase their market share.
Sugarmade’s continued efforts to develop a farm-to-door vertically integrated cannabis business position it to capitalize on these trends as the California cannabis industry continues to expand moving forward.

Management

Jimmy Chan is the CEO of Sugarmade. He is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Sugarmade, Inc. (OTC: SGMD), closed Thursday's trading session at $0.00205, up 2.5%, on 49,332,649 volume with 207 trades. The average volume for the last 3 months is 117.796M and the stock's 52-week low/high is $0.000699999/$0.019999999.

Recent News

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, nutraceuticals, cosmetics, agriculture, and food & beverage industries, today announced that its newly-formed agrochemicals subsidiary - PBI Agrochem, Inc. - has received initial purchase orders for over $1M of eco-friendly agrochemical products for delivery in 2021. Just three weeks ago, the Company announced the formation of its new agrochemicals division in anticipation of the planned asset acquisition of a global agrochemicals products business focused on organically natural and environmentally responsible products.

 

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions — all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed Thursday's trading session at $2.72, off by 6.2069%, on 99,965 volume with 195 trades. The average volume for the last 3 months is 57,951 and the stock's 52-week low/high is $1.28999996/$4.98000001.

Recent News

American Cannabis Partners

The QualityStocks Daily Newsletter would like to spotlight American Cannabis Partners.

American Cannabis Partners (“ACP”), a sustainable Jamaican experience canna-business innovator, prides itself on its close personal and positive relationship with Jamaica and its people, one founded on the profound awareness of needs and not just business numbers. “The company is committed to taking a similar approach to building relationships with its partners, striving to build synergistic relationships and position itself as a reliable business ally,” reads a recent article. It has partnered with Soilscape Solutions, a company helping rejuvenate soil fertility through sustainable soil practices, and Link4 Corporation, a company manufacturing software and environmental controls for growers. “Partnerships like these can produce exceptional results, and the words of American Cannabis Partners COO, Gary Coltek, attest to this. ‘Having industry partners like Soilscape and Link4 Systems have made it possible to replicate exact soil conditions, growing supplements, water makeup, and environments that mimic Orange Hill in Jamaica. The level of detail given to our plants has resulted in yields well above industry norms and producing some of the most sought-after flower in the U.S., especially our new patent-pending strains under the brand name ZUK where the entire crop has been pre-sold for 2021,’ said Coltek.” To view the full article, visit https://ibn.fm/oyJb8

American Cannabis Partners (ACP) is a multi-state cannabis company with 560,000 square feet of licensed canopy space for cultivation and one retail license. The company is nationally headquartered in Trinity County of Northern California’s Emerald Triangle.

ACP is focused on three complementary business segments: real estate, acquisition & development of proprietary assets, and ongoing cultivation operations. Led by a seasoned management team with 30+ years of canna-business experience, ACP’s strategy is to capture opportunities in real estate and licensing in states that have recently passed cannabis legalization legislation, thereby equipping the company to capitalize on Federal interstate commerce opportunities.

Through its current cultivation operations, ACP supplies approximately 80% of its whole flower products for manufacturing, distribution and retail licenses. With the remaining 20%, the company supplies its proprietary strains to select California distributors and its own Michigan retail location under its exclusive in-house brand, ZÜK.

History of American Cannabis Partners

In 2014, Stephen Jordan, President of ACP, took on the Director of Operations position for a U.S.-based company operating in the Jamaican cannabis space. Over the course of his three-year tenure in this role, Jordan developed a number of relationships that would help serve as the basis of American Cannabis Partners.

One such relationship was with Junior Gordon, a cultivation lead grower from Jamaica’s Westmoreland Parish. Jordan immediately saw the value of Gordon’s unique skillset and credentials, and Gordon recognized Jordan’s heartfelt vision of bringing Jamaican culture to the rapidly developing U.S. cannabis space.

Guided by that mission, ACP’s unchanging goal is to improve the lives of individuals through cannabis and business.

Current Operations

Since its founding in 2018, privately-owned American Cannabis Partners has established a foothold in two key U.S. cannabis markets – California and Michigan. In total, the company has acquired 12 cannabis licenses, including 20,000 sq. ft. of cultivation licenses in California and 540,000 sq. ft. of cultivation licenses & one retail license in Michigan.

ACP’s IP portfolio features three proprietary strains sold exclusively through the company’s wholly owned ZÜK brand, as well as proprietary data collection and mining systems supporting its cultivation and retail operations.

Plans for Expansion

American Cannabis Partners is pursuing additional growth in the cannabis sector through multiple planned initiatives. These include:

  • Submitting applications for additional cultivation licenses at the company’s Trinity County, California, location;
  • Planning land acquisition and project development strategies for expanding operations to its third U.S. state beginning in the second quarter of 2022; and
  • Planning land acquisition and project development strategies for expanding operations to its fourth U.S. state beginning in the second quarter of 2024.

ACP is currently exploring expansion opportunities through partnerships and joint ventures in New Jersey, New York, Virginia, Nevada, Arizona, Missouri and Massachusetts.

Management Team

Stephen Jordan is the CEO of American Cannabis Partners. He is focused on the first and last steps of legal cannabis – cultivation and retail. To date, Mr. Jordan has provided the company with ownership of 12 licenses, three proprietary cannabis strains and multiple real estate assets. His background in cannabis operations and financial strategies has guided American Cannabis Partners’ efforts to produce consistently high-quality product for both the medical and recreational segments. Mr. Jordan has operated under cultivation, manufacturing, distribution, medical research (Univ. of West Indies), retail and exportation licenses in multiple countries, further strengthening his network within the cannabis industry.

Gary Coltek is the company’s Chief Operating Officer. He has credentials based in the culinary, hospitality and sustainability industries spanning over 40 years, including taking three companies public. Mr. Coltek has held management positions internationally with Ritz Carlton, Four Seasons, Trump Hospitality, Phymatrix and International Oncology Network. For 17 years, he was the founding member and partner of a private boutique consulting firm. He is currently a guest speaker and visiting professor at universities in Israel, China, Italy, the Netherlands and Peru, covering topics that include culinary sustainability, sustainable cannabis farming, organic sustainable farming and cannabis clinical studies.

Scot C. Crow is the Lead Corporate Counsel for American Cannabis Partners. He has extensive experience in corporate mergers & acquisitions and tax law. His clients rely on him to advise them with respect to their complex financial transactions and provide outside general counsel. Mr. Crow provides his clients proactive advice with respect to sensitive management matters, litigation management, day to day transactional needs and objective assessments for the development of successful business strategies. His experience includes serving as lead counsel for numerous mergers & acquisitions, private equity investments, private offerings, venture capital financings, mezzanine debt offerings, divestures and other related transactions, with an emphasis in the legalized marijuana segment.

Jacob Frenkel is the company’s Lead Compliance Counsel. He is the current Chair of Dickinson Wright’s Government Investigations and Securities Enforcement Practice. Mr. Frenkel’s solutions-minded approach to issues has earned him a reputation as an aggressive, tenacious, creative and proactive defense lawyer and litigator. After 14 years as a Senior Counsel in the SEC’s Division of Enforcement, U.S. federal criminal prosecutor and New Orleans Assistant District Attorney, Mr. Frenkel has practiced in the private sector for 20 years. His unique mix of corporate transactional, litigation and investigations defense clients extend well beyond the cannabis industry and cover a wide range of industries worldwide.

Junior Gordon is the Director of Cultivation for American Cannabis Partners. With 30 years of international cannabis cultivation experience in both the Caribbean and United States, Mr. Gordon is recognized as one of the top growers in the world. His skills span both controlled indoor and large volume outdoor harvest programs, giving him proficiency in nursery, propagation and indoor & outdoor grow strategies. As a winner of High Times and other notable Cannabis Cups, his focus is on connecting the dots between propagation, soil, irrigation, planting, harvesting, curing, processing and inventory control, bringing Jamaican cannabis cultivation best practices to American Cannabis Partners’ operations.

Recent News

chart

InMed Pharmaceuticals Inc. (NASDAQ: INM)

The QualityStocks Daily Newsletter would like to spotlight InMed Pharmaceuticals Inc. (NASDAQ: INM).

InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates as well as manufacturing technologies for pharmaceutical-grade rare cannabinoids, today announced its plans to participate at the upcoming H.C. Wainwright Ophthalmology Virtual Conference. According to the update, InMed’s CEO and President Eric. A. Adams and SVP of Pre-Clinical Research and Development Dr. Eric Hsu will present at the conference on Tuesday, Aug. 17, 2021. Adams and Dr. Hsu will provide an overview of the company’s ocular program, including INM-088, a topical eye drop formulation under development for the treatment of glaucoma. INM-088’s active pharmaceutical ingredient (“API”) is cannabinol, also known as CBN, a rare cannabinoid showing promise in its potential to provide neuroprotection and to reduce intraocular pressure of the eye. The on-demand presentation will be available at 7:00 a.m. ET on Aug. 17, 2021, accessible from the HC Wainwrights events platform. An archived replay of the presentation will be available on InMed’s website immediately following the conference for 90 days. To view the full press release, visit https://ibn.fm/1W2sS

InMed Pharmaceuticals Inc. (NASDAQ: INM) is a global leader in the manufacturing and clinical development of rare cannabinoids. InMed is a clinical stage company developing cannabinoid-based pharmaceutical drug candidates, as well as manufacturing technologies for pharmaceutical-grade rare cannabinoids.

The company is dedicated to delivering new therapeutic alternatives to treat conditions with high unmet medical needs. The company is also developing a proprietary manufacturing technology to produce pharmaceutical-grade rare cannabinoids in the lab and has recently announced an LOI to acquire a leading rare cannabinoid manufacturer.

Research and Technology

There are more than 100 rare cannabinoids found in only trace amounts in the cannabis plant, together making up less than 1% of the plant’s biomass. InMed is initially focused on the therapeutic benefits of cannabinol (CBN) in diseases with high unmet medical need. Preclinical studies of CBN demonstrated an excellent safety profile and showed CBN has potential for therapeutic benefit over other cannabinoids such as tetrahydrocannabinol (THC) and cannabidiol (CBD).

Evidence suggests there may be great therapeutic potential in rare cannabinoids. Each has a specific chemical structure, and different cannabinoids have been observed to have distinct physiological properties in humans, including therapeutic potential for specific diseases as well as unique safety profiles. CBN is the active pharmaceutical ingredient (API) in InMed’s two lead programs for dermatological and ocular diseases.

InMed’s most advanced compound, INM-755, is a CBN topical cream under clinical development for the treatment of epidermolysis bullosa, a severe genetic skin disorder. To date, INM-755 has been evaluated in two Phase 1 clinical trials in healthy volunteers. InMed has filed Clinical Trial Applications in several countries as part of a global Phase 2 clinical trial of INM-755 (cannabinol) cream in epidermolysis bullosa. Responses from the National Competent Authorities and Ethics Committees are expected throughout the summer of 2021.

InMed is also involved in developing INM-088, an ocular CBN formulation being researched for the treatment of glaucoma, the second leading cause of blindness in the developed world. InMed is currently evaluating several formulations to deliver CBN into the eye to address issues of dosing frequency, side effects and treatment penetration. INM-088 is being designed for topical delivery to the eye. This localized delivery results in very little drug being absorbed or migrating into the bloodstream, thus minimizing potential adverse side effects. INM-088 shows promise to reduce intraocular pressure and provide neuroprotection of the eye.

Manufacturing

The limited availability of rare cannabinoids like CBN makes them economically impractical to extract directly from the plant for pharmaceutical use. InMed is developing IntegraSyn, a cannabinoid synthesis manufacturing system to create rare cannabinoids in the lab that are bioidentical to the compounds derived from the cannabis plant. IntegraSyn uses multiple standard pharmaceutical processes and has achieved a cannabinoid yield of 5 grams per liter, surpassing commercial viability and significantly exceeding currently reported industry yields. InMed is now focusing on manufacturing scale-up to larger batch sizes while continuing process optimization, targeting increased cannabinoid yield and further reducing overall cost of goods.

BayMedica Inc. Acquisition

On June 29, 2021, InMed announced it had entered into a non-binding letter of intent to acquire BayMedica Inc., a private company based in Nevada and California that specializes in the manufacture and commercialization of rare cannabinoids.

As noted in the news release, BayMedica is a revenue-stage biotechnology company leveraging its significant expertise in synthetic biology and pharmaceutical chemistry to develop efficient, scalable and proprietary manufacturing approaches to produce high quality, regulatory-compliant rare cannabinoids for consumer applications. BayMedica is currently commercializing the rare cannabinoid CBC (cannabichromene) as a B2B supplier to distributors and manufacturers marketing products in the health and wellness sector. BayMedica is planning additional rare cannabinoid launches for the coming year.

Pursuant to the indicative terms of the LOI, InMed and BayMedica intend to negotiate and enter into a definitive agreement under which InMed would acquire 100% of BayMedica in exchange for 1.6 million InMed common shares to be issued to BayMedica’s equity and convertible debt holders, with any such issued InMed common shares being subject to a six-month contractual hold period.

Market Outlook

There is a rapidly growing demand for rare cannabinoids. However, their low natural concentration makes traditional harvesting of these compounds cost prohibitive. Biosynthesis allows production of rare cannabinoids in the lab that are bioidentical to compounds found in nature, with significantly higher yields which reduce costs. Biosynthesis can produce pharmaceutical-grade, bioidentical, THC-free compounds at a cost that’s 70 to 90 percent less than wholesale prices of naturally harvested rare cannabinoids.

Cannabinoid-based pharmaceuticals are expected to overtake the market as rare cannabinoids become less expensive and more available. According to Statista, the value of the consumer market for cannabinoid-based pharmaceuticals in the United States is forecast to grow to $25 billion by 2025 and to $50 billion by 2029, with cannabinoid-based pharmaceuticals used to treat health conditions including pain, respiratory conditions, autoimmune conditions and more.

Management Team

Eric A. Adams has been CEO and president of InMed since June 2016. He has more than 25 years of experience in establishing corporate entities, capital formation, global market development, mergers and acquisitions, licensing and corporate governance. He previously served as CEO at enGene Inc. Prior to enGene, he held senior positions in global market development with QLT Inc. (Vancouver), Advanced Tissue Sciences Inc. (La Jolla, CA), Abbott Laboratories (Chicago, IL) and Fresenius AG (Germany).

Bruce S. Colwill is InMed’s CFO. He has more than 25 years of financial leadership experience in public and private companies. Prior to InMed, he served as CFO of General Fusion Inc., a private clean energy company. He was also CFO at Entrée Resources Inc., a mineral exploration company, from 2011 to 2016. He has held CFO roles at Neuromed Pharmaceuticals Ltd., Response Biomedical Corp, Forbes Medi-Tech Inc. and Euronet Worldwide Inc.

Alexandra D.J. Mancini is Senior Vice President, Clinical and Regulatory Affairs at InMed. She has more than 30 years of global biopharmaceutical research and development experience. She has been an executive with numerous biotech companies, including senior vice president of Clinical and Regulatory Affairs at Sirius Genomics; senior vice president of Clinical and Regulatory Affairs at INEX Pharmaceuticals; and vice president of Regulatory Affairs at QLT Inc.

Eric C. Hsu is Senior Vice President, Pre-Clinical Research and Development at InMed. He joined InMed with more than 18 years of scientific leadership experience in the field of gene therapy. He has held various positions within enGene Inc., including vice president of Research and vice president of Scientific Affairs and Operations. He received his Doctorate from the Department of Medical Biophysics at the University of Toronto.

Michael Woudenberg is Vice President, Chemistry, Manufacturing and Controls at InMed. He has more than 20 years of successful drug development, process engineering, GMP manufacturing and leadership experience. He has held positions with 3M, Cardiome Pharma, Arbutus Biopharma and, most recently, was Managing Director of Phyton Biotech LLC.

InMed Pharmaceuticals Inc. (INM), closed Thursday's trading session at $2.47, off by 1.5936%, on 26,663 volume with 212 trades. The average volume for the last 3 months is 68,568 and the stock's 52-week low/high is $2.20000004/$6.42000007.

Recent News

ISW Holdings Inc. (OTC: ISWH)

The QualityStocks Daily Newsletter would like to spotlight ISW Holdings Inc. (OTC: ISWH).

ISW Holdings (OTC: ISWH), a Nevada-based portfolio company with primary commercial-stage operations in cryptocurrency mining, recently secured $8 million in funding from California-based RB Capital Partners Inc. “In addition to the actual funding, conditions of the funding stipulate that any capital acquired through the arrangement will be used for further development, including the infrastructure necessary to strengthen and expand cryptocurrency mining operations at ISWH’s new mining facility in Georgia, including the assembly and outfitting of additional POD5 mining pods. The funds can also be used for value-adding strategic investments, such as technology, resources and personnel capable of maximizing the efficiency of ISWH’s operations,” reads a recent article. The piece quotes Alonzo Pierce, ISW Holdings president and chairman, as saying, “ISW Holdings has built a model with robust growth potential, and we’re excited that RB Capital has seen around that corner and was willing to provide growth-friendly terms on an important piece of the financial foundation necessary to actualize that potential. Given the timing of our agreement in Georgia and recent geopolitical shifts in the global cryptocurrency mining landscape, we are positioned very well at this point, and we look forward to a number of significant developments over coming weeks.” To view the full article, visit https://ccw.fm/upFLy

ISW Holdings Inc. (OTC: ISWH), through its in-house initiatives and strategic partnerships, has invested in growing operations targeting the telehealth and cryptocurrency mining industries.

The company specializes in strategic brand development and early growth facilitation. Management maneuvers its proprietary companies through critical stages of market development, including conceptualization, go-to-market strategies, engineering, product integration and distribution efficiency.

Mission

The company’s core mission is to enhance these sectors by implementing innovative services and products that are ready to meet the demands of a changing world. To that end, ISW Holdings leverages its strategic expertise, resources and innovative software to establish market-leading companies and partnerships, thereby ensuring success in their chosen industries.

Cryptocurrency Mining

The start of 2021 saw a massive resurgence in interest surrounding bitcoin and cryptocurrency mining. In mid-February, bitcoin prices hit an all-time high of greater than $57,000, and heightened demand for cryptocurrency mining power has played a key role in exacerbating a global shortage of semiconductors and computer components.

With a foothold in the cryptocurrency mining space, ISW Holdings has placed significant focus on expanding its position and capitalizing on this momentum. Recent highlights include:

  • February 9, 2021: The company announced that its revolutionary Pod5 Cryptocurrency Mining Pod will be powered up into full operational launch at the Bit5ive renewable energy cryptocurrency mining facility in Pennsylvania on February 12, 2021.
  • February 11, 2021: The company announced that it is in negotiations to purchase a large number of miners (between 300 and 900) in preparation for its coming Phase 3 expansion in mining volume.
  • February 23, 2021: The company announced its entry into a comprehensive Hosting and Maintenance Agreement prior to going online with its new ASIC s17 miners.
  • March 2, 2021: The company announced that it has successfully tripled its active cryptocurrency mining fleet with the addition of two new POD5IVE datacenters.

“As we continue to bring our miners online, we want our shareholders to be able to track the expansion and profitability of the company’s mining activity given the sharp rising trend in bitcoin prices,” Alonzo Pierce, President and Chairman of ISW Holdings, stated in a news release. “It currently costs about $11K in computing power to mine a single bitcoin. Bitcoin is pricing at over five times that level, making this is an exceptional ROI opportunity, and our responsibility to our shareholders is clear: continue to invest, expand and execute.”

Business Innovations

ISW Holdings’ diverse portfolio reflects the growing demand for essential services in a dynamic modern operational landscape. Some of the company’s current holdings and partnerships include:

  • Bit5ive LLC: ISW Holdings operates a joint venture with Bit5ive, a global leader in cryptocurrency mining. The joint-venture agreement enables ISW Holdings to collaborate with the experienced team at Bit5ive to innovate the infrastructure needed to run profitable and efficient crypto mining projects.
  • Proceso LLC: ISW Holdings has partnered with Proceso LLC to create high-density processing and mobile data centers powered by renewable energy. These innovations will allow Proceso to offer lower-cost and diverse services to its clients, including hosting and colocation services to growing sectors such as the gaming industry and cryptocurrency mining.
  • PHH Health: The company’s home health division answers the growing need for home care services in a world where health care delivery is changing and an increasingly large aging community is looking for efficient and effective ways of accessing health care.
  • Volum: The company’s logistics and supply chain management division is designed with the core goal of increasing supply chain efficiency, which is recognized as one of the key aspects of successfully growing any business.

Market Opportunity

ISW Holdings’ recent activity in the cryptocurrency mining sector has positioned it to capitalize on the forecast expansion of the cryptocurrency market in the coming years. According to data from MarketsandMarkets, the cryptocurrency space was valued at $1.03 billion in 2019 and is projected to reach $1.40 billion in 2024, achieving a CAGR of 6.18% during the forecast period.

The report suggests that major drivers for this growth will be the transparency of the underlying blockchain technology, the high volume of remittances in developing countries, the high cost of international remittance, expected fluctuations in monetary regulations and sustained investment in the cryptocurrency space by venture capital firms.

Management Team

Terry Williams is the Chief Executive Officer and Director of ISW Holdings. Mr. Williams brings to the company more than 30 years of experience in accounting and information systems, logistics, insurance and transportation. With a Bachelor’s and Master’s degree in accounting and management information systems, he amassed considerable corporate experience at UPS (NYSE: UPS), where he took several logistical roles, managing more than 2,000 employees and a budget of more than $10 billion. Mr. Williams also serves as president of Airware Transportation and Logistics and Chief Financial Officer of AVI Insurance Caribbean. In 2013, he received the National Airport Minority Advisory Council Award for mastering skills in the aviation industry.

Alonzo Pierce is the company’s President and Chairman. He brings a wealth of business development and wealth management experience to the ISW team, having spent the past 20 years building recognizable brands in multiple industry sectors. Mr. Pierce has launched enterprises in life-styled brands which were delivered to high-profile, high-net worth families and individuals. He has worked in the adult beverage industry, establishing a formidable background in marketing and brand creation. Pierce has a B.A. from Baylor University and has received multiple awards in the adult beverage industry, including ‘Outstanding Sales Performance in the Southern Region’ for Sapphire Brands. Pierce also served as a national liaison to a Super-Regional Bank’s private wealth division. In addition to his for-profit endeavors, Pierce has served on multiple charitable boards, sourcing funding for JRA, food insecure families and housing insecure families.

Kristina Mahoney-Brown is Secretary, Treasurer and Director of ISW Holdings. With more than 20 years of experience providing tax and financial consulting to real estate companies, as well as investors, developers and construction companies, Ms. Mahoney-Brown has gained solid business expertise and market knowledge and prides herself on staying abreast of the latest industry trends. Her professionalism, impeccable work ethic and advanced marketing strategies have earned her the nickname ‘The Tax Diva’. Mahoney-Brown has a Bachelor’s in accounting, a Master’s in taxation and a Master’s in business administration, specializing in personal financial planning.

ISW Holdings Inc. (ISWH), closed Thursday's trading session at $0.67, off by 8.8311%, on 423,221 volume with 247 trades. The average volume for the last 3 months is 777,984 and the stock's 52-week low/high is $0.0152/$1.47000002.

Recent News

Perpetual Industries Inc. (OTC: PRPI)

The QualityStocks Daily Newsletter would like to spotlight Perpetual Industries Inc. (PRPI).

Perpetual Industries (OTC: PRPI), in January 2021, completed the acquisition of Worldwide Group LLC, operating as Worldwide Auctioneers. A few months later, in April, the company took another critical step forward with the acquisition of AutoGrafic Software System. Both acquisitions were aimed at firmly establishing the company's position in a multibillion-dollar classic car market. The purchase of Worldwide Auctioneers, a U.S.-based boutique auction company specializing in the sale and acquisition of classic vintage motorcars at auctions around the world, was against the backdrop of the significant potential of the U.S. classic car market, expected to grow at a CAGR of more than 7% from 2020 to 2023. AutoGrafic Software System, a software as a service ("SaaS") and social application that utilizes cutting-edge technology to host many aspects of automotive promotion and preservation, targets global collector car and automotive enthusiasts. A recent article quotes PRPI CEO Brent Bedford as saying, "This acquisition provides another fundamental piece in our quickly expanding blockchain division. . . It will also greatly benefit Worldwide Auctioneers, our newly acquired wholly owned subsidiary, by bringing much-needed new technology and innovation to their customers and the collector car industry at large." To view the full article, visit https://ccw.fm/4aDHV

Perpetual Industries Inc. (OTC: PRPI) is an incubator for the development of innovative, energy-efficient technologies aimed at commercializing products that have the potential to impact and advance a wide range of industries on a global scale.

The company’s team of experts and trusted industry partners have the resources to provide essential components needed to take projects from their initial stages through to the end products. Perpetual Industries values strict controls and high levels of quality through all stages of research, development, manufacturing and commercialization.

Perpetual Industries was founded by President, Chairman and CEO Brent W. Bedford in 2005. It is located in Auburn, Indiana.

R&D Portfolio Overview

Perpetual Industries is expanding expertise and knowledge of energy-efficient technology by developing low-cost, green energy solutions for various industries, including artificial intelligence, blockchain mining, graphic rendering, renewable energy, cloud computing and internet of things (IoT), all while continuing research, development and commercialization of its proprietary XYO Balancing Technology in key applications.

XYO Balancing Technology

XYO Balancing Technology delivers high-performance solutions for inefficiencies that commonly affect rotating equipment, machinery and devices. It is designed to harness rotor displacement energy to move compensating masses and automatically correct for imbalances, effectively reducing vibration.

Key highlights of the company’s XYO Balancing Technology include:

  • Customized XYO balancers can be created for almost everything that rotates, providing virtually unlimited potential applications.
  • XYO Balancing Technology is optimized specifically to eliminate vibration in rotating equipment and enable environmentally responsible products to operate more efficiently.
  • Leveraging a proprietary design, XYO Balancing Technology is the result of over 25 years of research and development effort.

WindSilo – Vertical Axis Wind Turbine

Implementing its proprietary XYO Balancing Technology, Perpetual Industries’ WindSilo turbine improves balancing issues that are common in most wind turbines today. The company’s design is engineered to allow for much faster spin speeds and greater energy output.

The company believes that this innovative turbine design could eliminate the expensive traditional methods of balancing wind turbines while increasing their performance, reliability and efficiency.

In November 2020, Perpetual Industries announced that Trine University, a private post-secondary institution located in Angola, Indiana, had been awarded a grant to assist the company in the development of the WindSilo.

The XYO Washing Machine

Perpetual Industries is currently developing a proprietary domestic washing machine design implementing XYO Mechanical Balancers to dynamically compensate for variable mass imbalance during the spin cycle. The company expects these efforts to produce a number of benefits, including higher spin speeds, reduced energy consumption, decreased noise emissions and less mechanical wear & tear.

The company’s research shows tremendous market potential for a more efficient washing machine design. With an estimated 70 million washing machines produced annually and over 500 million used daily, even a small reduction in energy consumption could be pivotal. Reducing energy usage of all washing machines by just 15% would save enough energy to power the city of Milan. Perpetual Industries’ energy efficient design is expected to reduce energy usage by up to 50%.

Prototype testing of Perpetual Industries’ design has established the XYO Washing Machine as highly effective at reducing vibration when built into the spin basket assembly.

Green Energy Mining System

Using its expertise and knowledge of environmentally friendly technologies, Perpetual Industries is developing low cost, environmentally responsible energy solutions for powering large scale blockchain mining operations.

The company’s Green Energy Mining (GEM) System is being hailed as the next generation of energy efficient cryptocurrency mining. Powered by renewable & surplus energy sources such as wind, solar, natural gas, wind and geothermal that utilize battery storage technology, the platform addresses rising demand for computing power.

Renewable Energy Market Outlook

The global renewable energy market was valued at $928 billion in 2017 and is expected to continue expanding at a CAGR of 6.1%, resulting in a value of $1.5 trillion by 2025, according to Allied Market Research (https://ibn.fm/C06xF). Hydroelectric power is projected to be the most lucrative segment of the entire global renewable energy industry, followed by the wind, bioenergy, solar and geothermal segments.

Worldwide Auctioneers Acquisition

In January 2021, Perpetual Industries announced its acquisition of The Worldwide Group LLC, operating as Worldwide Auctioneers.

Worldwide Auctioneers is a U.S.-based boutique auction firm specializing in the sale and acquisition of classic vintage motorcars at auction around the globe. With an impressive 20-year history and a talented team, Worldwide offers an extensive range of personalized services to collectors, including private sales, appraisal, collection direction and consultancy, estate planning and asset management.

Perpetual Industries expects Worldwide to benefit from multiple channels of collaboration moving forward, particularly within the company’s blockchain division.

Classic Car Market Outlook

The U.S. classic car market has recorded steady expansion over recent years, accounting for revenue of approximately $12.63 billion in 2020, according to Statista (https://ibn.fm/Fydhj). The same report forecasts growth to $15.52 billion by 2023, representing a CAGR in excess of 7 percent. Classic car dealers in the U.S. have cornered a significant portion of this market opportunity. According to data from IBISWorld (https://ibn.fm/k30F5), the market for classic car dealers in the U.S. was valued at $2.1 billion in 2021, achieving a CAGR of 1.5% from 2016 to 2021, despite the challenges associated with the COVID-19 pandemic.

Management Team

Brent W. Bedford is the President, Chairman, CEO and founder of Perpetual Industries. He has held these roles continuously since founding the company in January 2005. He has a deep understanding of every aspect of the company’s business, products and markets. He also has experience developing corporate strategies, assessing emerging industry trends and carrying out business operations. Mr. Bedford has a strong background in mechanical applications, with expertise in finance, private startups, public startups and corporate turnarounds.

Carl Dilley is Director and COO of the company. He is a career entrepreneur who has served as a C-level officer in many different companies across multiple industries. Mr. Dilley has been instrumental in taking over 400 companies public. He has been involved in the investment industry since 1983. He has held FINRA series 24, 66 and 7 Securities licenses, allowing him to perform retail, investment, banking and new listing services functions.

William Griffin Thomas, CPA, is the company’s CFO. He holds a Bachelor of Science in Accounting from the University of Tampa and a Bachelor of Science in Agribusiness from the University of Florida. Mr. Thomas is a licensed CPA with over 19 years of experience spanning both the private and public sectors, as well as time with non-profits. His expertise includes auditing, budget analysis, fixed assets, financial modeling, SEC financial reporting, GAAP compliance and fair value measurements.

Perpetual Industries Inc. (PRPI), closed Thursday's trading session at $0.15, off by 31.8182%, on 10,068 volume with 5 trades. The average volume for the last 3 months is 13,659 and the stock's 52-week low/high is $0.063000001/$0.925000011.

Recent News

Brain Scientific Inc. (OTCQB: BRSF)

The QualityStocks Daily Newsletter would like to spotlight Brain Scientific Inc. (OTCQB: BRSF).

Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company focused on neurology, appears poised for rapid growth as the application space for EEG-based solutions expands. “With its current and future products, including disposable EEG headsets for neurological patients, long-term monitoring solutions, and AI-empowered technology for recording brain activity, the company appears well-placed within the growing brain monitoring space,” reads a recent article. This comes as the brain-computer interface (“BCI”) field is growing rapidly, representing one of the main driving factors behind the expansion of EEG technology. It is a promising approach to overcoming paralysis by decoding brain signals directly from the scalp and translating them into movements of a virtual or robotic effector. This powerful technology can provide opportunities for motor rehabilitation from a number of conditions and even help patients who’ve lost the ability to speak. “Committed to pushing the boundaries of what’s possible in the neurology space, Brain Scientific brings the groundbreaking technology that aims to enable what was inconceivable until recently.” To view the full article, visit: https://ibn.fm/oiwdT

Brain Scientific Inc. (OTCQB: BRSF) is a commercial-stage health care company focused on developing innovative and proprietary medical devices and software. With a mission of modernizing brain diagnostics by employing cutting edge technologies to bridge the widening gap in access to quality care, the company offers two FDA-cleared products that provide next-generation solutions to the neurology market.

The company’s proprietary, clinical-grade neurological devices are supported by its intellectual property portfolio featuring patents in the United States, China and Europe.

Brain Scientific’s first commercialized devices, NeuroCap(TM) and NeuroEEG(TM), are designed to disrupt the current electroencephalogram (EEG) market by offering cost-effective and disposable substitutes to existing solutions, allowing medical professionals to collect diagnostic information quickly.

The company’s goal is to improve diagnostics by leveraging artificial intelligence and machine learning processes to analyze a database of brain readings as a method of detecting seizures and dementia. The company is also working to improve patients’ access to neurological care.

Headquartered in New York, Brain Scientific and its predecessor (and now wholly owned subsidiary, MemoryMD Inc.) was founded in 2015 and went public in 2018.

Brain Scientific’s first phase of development, from 2018 to 2019, saw the inception of portable, clinical-grade, easy-to-use neurological devices. The second phase, currently ongoing, aims to create cloud-based, secure infrastructure to transmit patient data between patients and their neurologists. The company’s third phase of development is scheduled for 2021-2022 and is expected to focus on the use of AI-assisted diagnostic analysis to increase the efficiency, consistency and accuracy of neurology specialists.

NeuroCap(TM) – Disposable EEG Headset

The NeuroCap is a disposable pre-gelled EEG headset featuring 22 electrodes and 19 active EEG channels, all adhering to the international 10-20 system. The NeuroCap was FDA-cleared in 2018. The headset can be used for recording EEGs in virtually any setting, including urban and rural emergency departments, neurology clinics, urgent care clinics, ICUs, nursing homes, assisted living facilities and remote clinical research labs.

Through a universal cable adapter, the NeuroCap is compatible with other EEG amplifiers. The cap also works in parallel with Brain Scientific’s NeuroEEG amplifier, initiating EEG studies in less than five minutes.

The company is currently seeking FDA approval for additional features for the NeuroCap, as the device has the potential to fill a gap in EEG testing availabilities during the current coronavirus pandemic: in October 2020, Brain Scientific filed an Emergency Use Authorization (EUA) application. The EUA is required for the rapid distribution of the NeuroCap device to emergency departments, intensive care units and other treatment centers to administer prescriptive EEGs safely on critically ill patients or those suspected of being diagnosed with COVID-19.

With more than 80 percent of hospitalized patients infected with COVID-19 displaying neurological symptoms, the NeuroCap could prove to be a valuable device by offering fast testing with limited contact between technicians and patients.

NeuroEEG(TM) – Miniature and Portable Wireless EEG Amplifier

The NeuroEEG is a compact, portable and affordable wireless EEG amplifier intended for prescription use. The 16-channel, FDA-cleared, clinical-grade device acquires, records, transmits and displays electrical brain activity for patients of all ages.

Both the NeuroCap and NeuroEEG are delivered by MemoryMD Inc., a wholly owned subsidiary of Brain Scientific.

Products in Active Development

Currently, Brain Scientific and MemoryMD are working on leveraging their existing products and drawing from ongoing research to develop and commercialize the next generation of solutions for the brain diagnostics market. The devices under development are being designed to address the following issues:

Routine EEG

  • NeuroCap-8 is an 8-channel EEG cap. The reduced number of electrodes is vital in emergency room situations, where the time it takes to set up the EEG is critical.

Pediatric EEG

  • NeuroCap Pediatric is positioned to become the first disposable and pre-gelled headset available for the pediatric market.

Long-Term Monitoring

  • NeuroCap LTM for adult and pediatric patients is a disposable cap designed to monitor rhythmic and periodic patterns for up to 72 hours, providing essential diagnostic capabilities.
  • NeuroEEG 24 Channel Amplifier is a portable and wireless amplifier with over 24 hours of battery life.

Artificial Intelligence

  • Brain E-Tattoo is a minimally invasive four-channel EEG electrode designed for long-term monitoring.
  • An AI database of brain biomarkers collects data on both normal and abnormal brain data to detect neurological diseases. The goal is for machine learning algorithms to enhance understanding of brain-behavior related to epilepsy, memory dementia and pre-Alzheimer’s diagnostics.

Telemedicine

Brain Scientific is expanding the vision for telemedicine in neurology. The company aims to address the current acute neurologist shortfall (20 states have less than 10 neurologists per 10,000 patients) through the use of teleneurology.

 

Partnership with Marketing Brainology

Brain Scientific has a longstanding partnership with Marketing Brainology, a neuromarketing firm using neuroscience approaches to understand consumer behavior. In 2019, Marketing Brainology conducted a study using NeuroCap and NeuroEEG to determine the most effective Super Bowl commercials.

“Thanks to Brain Scientific’s NeuroCap and NeuroEEG, we are able to better understand the art and science of the human decision-making process,” Michelle Adams, Ph.D, Founder of Marketing Brainology, stated in a news release.

In April 2020, Marketing Brainology again conducted a study leveraging Brain Scientific’s disposable EEG cap to determine how brains were reacting to COVID-19 messaging. Subjects were presented with multiple media impressions, and Marketing Brainology analyzed their responsive biomarkers. The results identified the most effective messaging for engaging with an audience during a crisis.

Market Outlook

The current global market for EEG devices is estimated at $956.1 million. It is expected to rise with a CAGR of 8.7% from 2019 to 2026, reaching $1.6 billion in value by 2026, according to Grandview Research.

In total, there are approximately 6,150 hospitals in the U.S., according to the American Hospital Association. Critically, though, just 254 of those hospitals are certified Level 4 Epilepsy centers with 24/7 EEG coverage. Since very few non-Level 4 centers have extensive EEG tech coverage, this creates a significant opportunity for Brain Scientific to bridge the gap by providing over 5,900 hospitals with lower cost amplifiers and disposable EEG caps.

The company also see opportunities to work with other businesses, such as EEG manufacturers hoping to package Brain Scientific’s solutions with their products, which could greatly expand Brain Scientific’s addressable target market.

Management Team

Dr. Baruch “Boris” Goldstein, Ph.D., is co-founder and Chairman of Brain Scientific. He is a seasoned executive with a proven talent for aligning global business strategies with established and emerging management teams. Goldstein’s growth-focused leadership style has helped him raise over $750 million in venture capital for the development of innovative companies and startups in diverse industries, including financial services, biomedicine, alternate energy and new materials, as well as groundbreaking work in artificial intelligence. His recent achievements include important advancements in neurology and unlocking the potential of AI correlations and machine learning applied to life sciences and medical research. He built a suite of first-to-market companies as a technology-oriented leader, including Ryah Medtech, Brain Scientific, GrapheneCA, E-Forex and Intelligent Video Systems. He also co-founded BrainRX, a company specializing in pre-Alzheimer’s diagnostics.

Dr. Nikolay Kukekov, Ph.D., is a Director of Brain Scientific and a partner at HRA Capital. Before joining HRA Capital, Kukekov was Managing Director of Healthcare Investment Banking at Summer Street Research. His scientific background includes a bachelor’s degree in Molecular, Cellular and Developmental Biology from the University of Colorado at Boulder. He earned his Ph.D. in neuroscience from Columbia University – College of Physicians and Surgeons in New York.

Stuart Bernstein is the company’s Vice President of Marketing. He was recently named to the role after spending the first part of his professional career in senior technical management roles with Fortune 500 companies such as NCR (NYSE: NCR), IBM (NYSE: IBM) and Control Data Corp. He was the CEO of BioSignal, an EEG medical device company. He is also a co-founder of several software engineering and telemedicine firms. One of them, Brain Saving Technology, is now Specialist on Call (SOC Telemed) – a leading telemedicine company that powers over 850 facilities for teleneurology, telepsychiatry and critical care telemedicine with over 200 physicians.

Brain Scientific Inc. (OTCQB: BRSF), closed Thursday's trading session at $0.3898, up 5.3514%, on 1,710 volume with 7 trades. The average volume for the last 3 months is 25,528 and the stock's 52-week low/high is $0.116099998/$2.20000004.

Recent News

Petroteq Energy Inc. (TSXV: PQE) (PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (TSXV: PQE) (PQEFF).

Petroteq Energy (TSX.V: PQE) (OTC: PQEFF) (FSE: PQCF), an oil ‎company focused on the development and implementation of its proprietary oil-‎extraction ‎technologies, has noted that the success of its ongoing testing in its Asphalt Ridge extraction plant has led to the production and sale of oil from this multi-sourced ore. The testing is on ore from various sources, with varying oil quality that ranges from 5 to 10 weight percent; the testing confirmed that Petroteq’s plant could handle the variations of ore source. Subsequently, the company produced a load of ore that was sold on Aug. 6, 2021. The announcement noted that the buyer loaded 236 barrels of 16.9° American Petroleum Institute (“API”) crude with a Basic Sediment and Water (“BS&W”) of 0.20%. The company also noted that UK-based Quadrise Fuels International plc has received several barrels of produced oil to assess the suitability of the heavy sweet oil for its MSAR(R) (“MSAR”) technology; that testing is slated to be done by the end of August 2021. “The company continues to produce extracted oil to validate the feasibility of our technology, enhanced by demonstrated plant production that shows the design can cover a wide range of ore quality, to give our stakeholders, suppliers and potential business partners more confidence in our capability, while we are also actively seeking to deploy the technology to a global market,” said Petroteq CEO Dr. R.G. Bailey  in the press release. To view the full press release, visit https://ibn.fm/8U247

Petroteq Energy Inc. (TSXV: PQE) (PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil sands exploration and production on mineral leases in Vernal, Utah, and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.

Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.

The Company’s Asphalt Ridge mineral lease on 2,500-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Clean Oil Recovery Technology (CORT) System.

The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.

The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.

Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ. PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.

“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy Chairman Alex Blyumkin.

In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry.

“API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.

Petroteq Energy Inc. (PQEFF), closed Thursday's trading session at $0.1802, up 7.2619%, on 2,457,592 volume with 267 trades. The average volume for the last 3 months is 4.084M and the stock's 52-week low/high is $0.032999999/$0.249500006.

Recent News

RYAH Group Inc. (CSE: RYAH)

The QualityStocks Daily Newsletter would like to spotlight RYAH Group Inc. (CSE: RYAH).

Despite being one of the youngest sectors in America, cannabis is one of the country’s fastest-growing spaces. Cannabis and hemp products have become extremely popular, with the sector being one of the few spaces emerging from the coronavirus pandemic relatively unscathed and actually seeing increasing sales. However, one issue that has plagued America’s state-legal cannabis industry has been cannabinoid testing. The 2018 Farm Bill, which legalized the cultivation and sale of industrial hemp and its cannabinoids, placed a 0.3% THC limit for legal hemp. But most laboratories that test for THC, CBD and other cannabinoids often come back with different results. Consequently, a federal science agency has launched a program to push for standardized testing and analysis of the more than 100 cannabinoids in hemp and cannabis. In that vein, the National Institute of Standards and Technology (“NIST”), which is part of the U.S. Department of Commerce, has recently published a THC and CBD testing variability report. The removal of any inconsistencies in the testing of THC and CBD levels in cannabis products is especially important for people who consume cannabis products for medicinal purposes, and more accurate testing coupled with the use of precision dose-measuring devices such as those made by RYAH Group Inc. (CSE: RYAH) would increase the likelihood of getting the desired results from the cannabis medicine.

RYAH Group Inc. (CSE: RYAH) is a leading digital health care analytics and technology company with a mission to advance the world’s transition to remote-health solutions and data analytics in patient treatments. Through the company’s IoT dose-measuring devices and AI analytics, RYAH is reshaping understanding of the value of devices combined with data, to positively impact the future treatment of patients for various medical conditions.

The company is a leading developer of dose-measuring IoT devices connected with its turn-key platform designed to aggregate and correlate HIPPA-compliant data, suitable to all participants in the patient treatment cycle. The company also specializes in customized, fully integrated, mobile applications and APIs, specifically designed to meet the needs of clinics, clinical trials, government and university research centers, for experimentation and treatment validation – significantly reducing variations in patient-related trials. RYAH unlocks data in the complete therapeutic plant lifecycle – from seed to consumption.

Since it began developing and commercializing its smart inhaler solution in 2018, the company has evolved a complete IoT device and data analytics platform that includes multiple delivery mechanisms, designed to capture anonymous patient dosing and feedback, combined with detailed strain analytics, enabling customized dosing regiments. The company has secured numerous partnerships across the globe, including establishing a footprint in the UK, USA, Australia and Canada, and it has closed several deals in the European Union, as well. The company’s Smart-Inhaler has been selected as the dose-measurement, dose-control and data analytics platform for a UK pain management study and one of the world’s most ambitious and largest clinical trials ever to be conducted in cannabis.

Product Portfolio

The company’s current portfolio incorporates an ecosystem of IoT products, each consisting of three elements: the device, the medicine-carrying component and the mobile application. The product line currently includes a Smart Dry-Herb Dose-Measuring Inhaler in the commercial stage, a Smart Transdermal Patch in the production stage and a Smart Liquid Dispensing Pen in the prototype stage.

RYAH Smart-Inhaler

The RYAH Inhaler is the first dry-herb inhaler that allows users to track and control how much is inhaled, providing consistent and predictable results. This inhaler connects with the RYAH Health App, which features stat-tracking and presets for temperatures and dosages, all of which can be customized to individual needs and doctor recommendations, as well as a post-session review mechanism that allows the collection of session data and feedback for further efficacy analysis for customized dosing capabilities.

RYAH’s proprietary stainless-steel cartridges for the inhaler use QR technology that contains lab testing and grower information pertaining to the specific strain, thereby mitigating elicit product use and enabling completely transparent remote medicinal analytics, from seed to consumption.

In addition, the RYAH Cartridges provide a unique closed-loop recurring revenue opportunity for the company, as the RYAH Inhaler only works with this type of proprietary cartridges that licensed partners fill with medicine. The partners benefit from all the back-end data, providing them access to consumption habits, statistics and other data on patient preferences.

RYAH Smart-Patch

The RYAH Smart Transdermal Patch is a lightweight, reusable, mobile-controlled patch used for site-specific therapies. The Patch is an Electronic Topical Delivery Patch system intended for recommendation and administration by pain relief professionals and physical and occupational therapists. The patch data and the heating element is completely IoT and controlled by RYAH’s proprietary smartphone applications, which allows scheduling and ‘boosting’ medicine release, on-demand.

RYAH Smart-Pen

The RYAH Pen is an app-controlled liquid dispenser designed to provide a precise mix of up to three medicine components to create an ‘entourage effect’, enabling customized, wide-spectrum recommendation opportunities by licensed clinicians. The Smart-Pen will feature cartridges that contain CBD, THC and other isolates such as flavonoids or vitamins, or other solutions. There is a built-in mechanism designed to control usage based on recommended dosing schedules.

RYAH MD

RYAH MD serves as a remote and interactive patient-doctor collaboration and dosing administration platform. Doctors can remotely set dosage amounts for their patients, creating digital prescriptions for the RYAH IoT devices and tracking patient usage in real-time. RYAH MD offers features that include real-time monitoring, appointment booking, doctor-patient video calls and science-based strain recommendations, as well as promoting a better understanding of the effects and benefits of those recommendations among patients. Information is gathered from all of the RYAH devices.

PotBot App

The PotBot App is a medical cannabis education mobile application that leverages patented AI technology to capture structured and unstructured data to assist patients in learning about various treatments in plant-medicine based on their efficacy goals. The PotBot App is currently one of the top-rated medical cannabis educational mobile applications on the Apple App Store in the United States, with over 300,000 downloads.

Through the combination of peer-reviewed and empirical data, the PotBot App provides detailed information on the targeted and tested cannabinoid levels and associated strains from cannabis patients. The result is personalized and driven by data to inform patients of potential product matches associated with similar ailments and efficacy goals.

Market Outlook

RYAH holds a unique position in the $100.3 billion medical plant market, with the potential to capture and capitalize on growth opportunities made available by both the IoT and Data Intelligence sectors.

In 2018, the global IoT market was valued at $212.1 billion, and it is expected to grow exponentially to $1.3 trillion by 2026, registering a CAGR of 25.68%, according to Verified Market Research (https://ibn.fm/XtkPZ).

Management Team

Dr. Boris Goldstein, Ph.D., is the founder and Chairman of RYAH Group. He is a seasoned entrepreneur, investment banker and venture capitalist. He started his career as the founder of Software House HT, which grew into a worldwide corporation with over 40 offices in 17 countries. Since then, Goldstein has founded and served on the boards of directors and advisory boards for numerous companies in Silicon Valley and Silicon Alley. Goldstein brings experience in fundamental research, investment and technology, authoring multiple patents and books.

Gregory Wagner, MBA, is Chief Executive Officer and Director of RYAH Group. He has over 20 years of experience in global financial markets and entrepreneurship. Wagner has held executive roles in the United States and London. He has co-founded and built several startups from the ground up. His current licensures and degrees include FINRA Series 7, 63, 24 and 55, as well as an MBA from Fordham University. Wagner received a Certification in Innovation and Strategy from Harvard University.

RYAH Group Inc. (CSE: RYAH), closed Thursday's trading session at $0.105, up 5.00%, on 276,105 volume with 34 trades. The average volume for the last 3 months is 512,692 and the stock's 52-week low/high is $0.055/$0.20.

Recent News

Predictive Oncology (NASDAQ: POAI)

The QualityStocks Daily Newsletter would like to spotlight Predictive Oncology (POAI).

Recently conducted research has discovered that cervical cancer can be detected by clinicians using a handheld microscope and a topical fluorescent imaging agent dubbed PARPi-FL. This imaging technique targets the PARP1 enzyme, which is overexpressed in this type of cancer. It has the potential to revolutionize cervical cancer biopsies and screenings. Cervical cancer is the fourth most common cancer in women. Data shows that in 2018, nearly 600,000 women were diagnosed with this cancer type globally, with roughly 310,000 of them succumbing to the disease. A lot of investment is being directed towards studying cancer because it is a global challenge impacting significant numbers of people. However, since cancer occurs in various forms, it has often been problematic to diagnose some forms early enough, and that may be why companies such as Predictive Oncology (NASDAQ: POAI) are focused on harnessing the power of data analytics and AI to improve diagnosis within the global oncology sector.

Predictive Oncology (POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer.

Through its subsidiaries, Predictive Oncology’s portfolio of assets includes the following:

  • A database of clinically validated historical and outcome data from patient tumors
  • An in-house Clinical Laboratory Improvement Amendments (CLIA)-certified lab
  • A “smart” patient-derived tumor profiling platform
  • An in-house bioinformatics artificial intelligence (AI) platform
  • A new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options
  • An FDA-approved fluid collection and disposal system

Using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries Predictive Oncology is working to determine the best pathways for more individualized and effective cancer treatment.

Subsidiaries

Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.

Helomics applies artificial intelligence to its rich data gathered from the company’s trove of more than 150,000 tumors to personalize cancer therapies for patients as well as drive the development of new targeted therapies in collaborations with pharmaceutical companies. This database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.

In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.

TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory without the use of rats or mice, allowing for the identification of biomarkers indicative of cancer. This methodology “fools” the tumor into thinking it is still in the body. As a result, the tumor reacts as it naturally would, thereby increasing the accuracy of the biomarker. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and helps categorize an individual patient’s heterogeneous tumor samples to enable development of patient-specific treatment options.

Skyline Medical’s patented, FDA-cleared STREAMWAY® System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.

The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.

Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.

Competitive Advantage

Precision medicine has become the holy grail of cancer therapeutics. Data driven predictive models of tumors and their responses are critical in both new drug development and individualized patient treatment. The race has begun to model various tumors, which takes 5 to 7 years of clinical evaluation to establish historical and outcome data.

Predictive Oncology enjoys significant competitive advantage. The company already has a vast historical collection of tumors and related data, plus the ability to obtain existing associated outcome data. While others wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine to reality. Predictive Oncology already has the clinical data, including how a tumor responded to certain drugs, an in-house bioinformatics AI platform, and only needs to do the tumor sequencing. The significance is underscored by the collaboration with UPMC Magee-Women’s Hospital, designed to reveal which mutations responded to which drug then develop powerful predictive models for future testing and treatment.

Leadership Team

Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.

CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.

Gerald Vardzel, President of Helomics, has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions. Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh.

Dr. Mark Collins, Chief Information Officer of Helomics, has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and founded three startup software companies in the machine learning and drug discovery space. In 2001, Dr. Collins worked for Cellomics (now part of Thermo Fisher Scientific), where he played a pivotal role in establishing the High-Content Cell Analysis market, building and commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commercialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK.

Predictive Oncology (POAI), closed Thursday's trading session at $1.03, up 0.980392%, on 829,902 volume with 3,680 trades. The average volume for the last 3 months is 2.799M and the stock's 52-week low/high is $0.629999995/$2.29999995.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

closed Wednesday's trading